This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The World Market For Stents (Drug-Eluting And Bare Metal Product Markets In US, EU, Japan, India, China And ROW)

Rest of the World

Revenue Forecast

 

 

 

CHAPTER SEVEN: COMPANY PROFILES

 

Abbott Laboratories

 

Biosensors International

 

Boston Scientific

 

Biotronik SE & Co.KG

 

CID Vascular

 

Elixir Medical Corporation

 

Medtronic

 

Meril Life Sciences Pvt. Ltd.

 

MicroPort Medical ( Shanghai) Co., Ltd

 

Minvasys

 

OrbusNeich

 

REVA Medical

 

Stentys S.A.

 

Terumo Corporation

 

LIST OF EXHIBITS

 

CHAPTER ONE: EXECUTIVE SUMMARY

 

Table 1-1: Top Ten Causes of Death in the World by Development Level, 2008

 

Figure 1-1: Global Market Revenues Forecast 2010-2017

 

(Bare Metal Stents, Drug Eluding Stents, Total)

 

CHAPTER TWO: CARDIOVASCULAR DISEASE OVERVIEW

 

Table 2-1: Top Ten Causes of Death in the World by Geographical Region, 2008

 

Table 2-2: Top Ten Causes of Death in the World by Development Level, 2008

 

Table 2-3: Top Ten Causes of Death in the World in High Income Countries, 2008

 

Table 2-4: Top Ten Causes of Death in the World in Middle Income Countries, 2008

 

Table 2-5: Top Ten Causes of Death in the World in Low Income Countries, 2008

 

Figure 2-1: Percentage of Deaths Related to Cardiovascular Disease in

 

the Seven Major World Markets, 2008

 

Table 2-6: Projected Deaths from Ischemic Heart Disease (IHD) and Acute

 

Myocardial Infarction (AMI) in the Seven Major World Markets, 2012

 

Table 2-7: Age-Standardized Mortality Rates for Ischemic Heart Disease (IHD)

 

and Acute Myocardial Infarction (AMI) by Gender in the Seven Major

 

World Markets, 2009

 

Table 2-8: Estimated Total Cost of Cardiovascular Disease in Europe, 2006

 

Table 2-9: Estimated Total Cost of Cardiovascular Disease in Major Markets, 2012

 

CHAPTER THREE: CORONARY STENTS OVERVIEW

 

4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,620.54 -109.57 -0.62%
S&P 500 2,061.95 -14.83 -0.71%
NASDAQ 4,970.1410 -39.0730 -0.78%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs